Ledger.Open graph →
SEC Form D · Amendment · filed May 16, 2018

Cyteir Therapeutics, Inc

Offering
$35.0M
Sold
$5.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Timothy Romberger · Cambridge, MAExec · DirectorBart Van Hooland · Cambridge, MADirectorMarkus Renschler · Cambridge, MAExec · DirectorRonald Goldstein · Cambridge, MAExecRacquel Bracken · Cambridge, MADirectorJean George · Cambridge, MADirectorPhil J. Schmitt · Grand Cayman, Cayman IslandsDirectorRonald Goldstein · Cambridge, MAExecGary R. Severson · GIG HARBOR, WAExec · DirectorMatei Zaharia · San Francisco, CADirectorMary Chan · Colorado Springs, CODirectorSteven D. Persky · Santa Monica, CAExec · DirectorRichard Kriss · Poulsbo, WAExecJohn Peers · CAMAS, WAExec · DirectorBenjamin B. Watsa · Santa Monica, CAExec · DirectorIon Stoica · San Francisco, CADirectorMarwan Hannon · Colorado Springs, CODirectorTaylor O'Neil · Dripping Springs, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗